Skip to main content
Premium Trial:

Request an Annual Quote

Aros to Provide Sequence Analysis on CLC Bio's Platform

Premium

European sequencing service provider Aros Applied Biotechnology is now offering its customers the option to receive their next-gen sequencing data in CLC Bio's format. Customers will also receive a time-limited license for the CLC Genomics Workbench.

The deal covers all steps, including extraction, sample banking, and analysis and advanced bioinformatics.

The two companies are also collaborating with other organizations in a $5 million sequence analysis project of formalin fixed, paraffin embedded tissues samples (IS 9/14/2010).

Financial terms of the recent deal were not disclosed.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.